1. Home
  2. AVDL vs STC Comparison

AVDL vs STC Comparison

Compare AVDL & STC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • STC
  • Stock Information
  • Founded
  • AVDL 2015
  • STC 1893
  • Country
  • AVDL Ireland
  • STC United States
  • Employees
  • AVDL N/A
  • STC N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • STC Specialty Insurers
  • Sector
  • AVDL Health Care
  • STC Finance
  • Exchange
  • AVDL Nasdaq
  • STC Nasdaq
  • Market Cap
  • AVDL 1.8B
  • STC 2.1B
  • IPO Year
  • AVDL 1996
  • STC N/A
  • Fundamental
  • Price
  • AVDL $23.50
  • STC $72.91
  • Analyst Decision
  • AVDL Buy
  • STC Buy
  • Analyst Count
  • AVDL 9
  • STC 2
  • Target Price
  • AVDL $18.06
  • STC $77.50
  • AVG Volume (30 Days)
  • AVDL 5.5M
  • STC 215.5K
  • Earning Date
  • AVDL 11-04-2025
  • STC 10-22-2025
  • Dividend Yield
  • AVDL N/A
  • STC 2.88%
  • EPS Growth
  • AVDL N/A
  • STC 69.60
  • EPS
  • AVDL N/A
  • STC 3.60
  • Revenue
  • AVDL $248,517,000.00
  • STC $2,796,513,000.00
  • Revenue This Year
  • AVDL $64.21
  • STC $17.67
  • Revenue Next Year
  • AVDL $30.80
  • STC $10.14
  • P/E Ratio
  • AVDL N/A
  • STC $20.26
  • Revenue Growth
  • AVDL 79.88
  • STC 16.09
  • 52 Week Low
  • AVDL $6.38
  • STC $56.39
  • 52 Week High
  • AVDL $23.57
  • STC $78.44
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 91.85
  • STC 57.26
  • Support Level
  • AVDL $18.74
  • STC $70.65
  • Resistance Level
  • AVDL $19.00
  • STC $74.30
  • Average True Range (ATR)
  • AVDL 0.25
  • STC 2.32
  • MACD
  • AVDL 0.20
  • STC 0.34
  • Stochastic Oscillator
  • AVDL 98.80
  • STC 83.48

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About STC Stewart Information Services Corporation

Stewart Information Services Corp is a customer-focused, title insurance and real estate services company offering products and services to home buyers and sellers, mortgage lenders and servicers, attorneys, and home builders. It has three operating segments; Title insurance and related services which generates key revenue, includes the functions of searching, examining, closing, and insuring the condition of the title to real property. It also includes home and personal insurance services, Real estate solutions segment supports the real estate mortgage industry by providing appraisal management services, online notarization and closing solutions, credit, and real estate information services, search and valuation services. Corporate and other segment is comprised of parent holding company.

Share on Social Networks: